The FDA has approved tafasitamab in combination with lenalidomide and rituximab for adults with relapsed/refractory ...

Beyond cancer treatments, scans, and countless appointments, there is another critical factor in a patient’s well-being: ...

Because of the selection of CDK4/6 inhibitors now available in the first-line setting for patients with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer, providers now have the ...

Because oncology nurses are at the forefront of patient care, they are uniquely positioned to facilitate cancer survivorship ...

Oncology nurses can play a key role in educating patients and supporting clinical trial participation for this new treatment ...

Oncology nurses can help patients and families understand the expectations of pediatric brain cancer survival, says Kasey Rangan, MSN, CPNP-PC, CPHON.

UGN-102 has received FDA approval for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

Nivolumab plus chemotherapy significantly improved OS vs chemo alone in resectable NSCLC, per updated CheckMate-816 findings.

Nurses are vital experts to the multidisciplinary oncology team who continue to expand their role in meeting the needs of ...

In addition to a significant PFS benefit vs nab-paclitaxel alone, the combination provides an at-home option for patients with ovarian cancer.

Oncology nurses and APPs can help reduce discrimination faced by patients with cancer who are members of the LGBTQIA+ ...